2025³â 07¿ù 08ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets

´º½ºÀÏÀÚ: 2024-06-27

WAGENINGEN, NETHERLANDS -- Bayer and Solynta have reached an agreement to collaborate on the commercialization and distribution of true potato seeds in Kenyan and Indian markets. This partnership marks Bayer’s entry into the 20 million hectare global potato market and its first collaboration with Solynta, a Dutch company developing robust hybrid potato varieties.

The collaboration will center around Solynta’s expert knowledge of potato breeding with the development of new robust potato varieties that will thrive in key potato growing geographies. This innovation will allow growers to plant potatoes from true seeds rather than the traditional planting of tubers. Bayer will distribute the new hybrid potato varieties to growers in remote areas of Kenya and India.

Using true potato seeds instead of seed tubers has several advantages for the potato industry. True potato seeds are smaller, cleaner, disease-free, have a long shelf life, and are easier to transport and store. They are available year-round and can be bred with additional beneficial traits such as disease resistance and climate resilience.

Bayer is adding true potato seeds to its portfolio as part of its regenerative agriculture strategy, focusing on resilient and sustainable food systems. “Seed innovation is one of our key focus areas,” said Frank Terhorst, Head of Strategy & Sustainability at Bayer’s Crop Science Division. “We expect Solynta’s true potato seeds to have a positive impact on local communities and on food and nutritional security.”

“Adding true potato seeds to our portfolio is a natural progression of our team’s work to support smallholder growers and offer the latest innovations,” said Inci Dannenberg, President, Global Vegetable Seeds, Bayer.

Peter Poortinga, CEO of Solynta, pointed out that the true potato seeds are the result of almost two decades of work on Solynta’s hybrid potato breeding technology. “Hybrid breeding is a proven technology in many existing food crops, which allows fast development of new varieties with desirable traits, such as disease resistances. We are delighted to join forces with Bayer on the introduction and distribution of our true potato seeds.”

“We are focused on introducing true potato seeds, and conducting field and commercial trials to demonstrate their effectiveness. We are thrilled to partner with Bayer for the further commercial roll-out in Kenya and India,” said Solynta’s CCO Joost van Regteren.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Expanding Creative Boundaries: LG Taiwan Launches Versatile IT Lineup for Modern Lifestyles
Galderma Launches Trials of Nemolizumab for Systemic Sclerosis and Chronic Pruritus of Unknown Origin
Toshiba Starts Sample Shipments of Second Product in its Smart Motor Control Driver ¡°SmartMCD¢â¡± Series
Versa Powers Swisscom¡¯s beem: The World¡¯s First Sovereign SASE Connectivity Service
Kioxia Unveils 8th Gen BiCS Flash SSDs to Boost AI And HPC GPU Efficiency
Faraday Delivers Latest SerDes IP to Complete Interface Lineup on UMC¡¯s 22nm Platform
LG Launches Upgraded webOS Hub With Advanced AI Solutions for Third-Party Brands

 

Lenovo Named a Major Player in IDC MarketScape for Hybrid IT Infrastru...
Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opp...
Lenovo Unveils New Generation of AI PC Desktops and Monitors Designed ...
Yokogawa Collaborates with Shell on Robotics and AI Technology for Pla...
NetApp Appoints Disruptive Innovator Syam Nair as Chief Product Office...
NetApp Report Highlights Fierce Competition in Global AI Leadership
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..